Search filters

List of works by Andrew J Ullmann

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

scientific article

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

scientific article

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

scientific article

Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents

scientific article published on 9 October 2017

Antifungal prophylaxis for invasive mycoses in high risk patients

scientific article published on December 2006

Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

scientific article published on 26 May 2012

CMV prophylaxis in hematopoietic-cell transplantation

scientific article published on 01 August 2014

Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT

scientific article published on 29 October 2019

Choosing a study population for the evaluation of antifungal prophylaxis

scientific article published in June 2005

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

scientific article published on 23 December 2015

Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.

scientific article published on 21 June 2016

Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer

scientific article published on 15 July 2015

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

scientific article published on 28 May 2013

Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies

scientific article published on 28 November 2005

Comparative Analysis of Inflammatory Cytokine Release and Alveolar Epithelial Barrier Invasion in a Transwell® Bilayer Model of Mucormycosis

article

Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation ⬇️

scientific article published on September 1, 2003

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)

article

Early Cessation of a Vancomycin-Resistant Enterococci (VRE) Outbreak in a Hematology-Oncology Department after Implementation of an Enhanced Infection Control Intervention. A Single Center Experience. ⬇️

scholarly article

Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation.

scientific article published on 7 December 2004

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting

scientific article published on 11 October 2007

Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany.

scientific article published in January 2006

Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease

scientific article

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry

scientific article published on 22 August 2009

Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.

scientific article published on 20 June 2013

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

scientific article

Estimated burden of fungal infections in Germany.

scientific article published on October 2015

Evaluation of Aspergillus and Mucorales specific T-cells and peripheral blood mononuclear cell cytokine signatures as biomarkers of environmental mold exposure

scholarly article by Lukas Page et al published September 2018 in International Journal of Medical Microbiology

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

scientific article

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

scientific article published on 05 November 2019

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial

scientific article published on 29 January 2010

Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species

scientific article published on 28 September 2009

Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

scientific article published on 10 September 2003

Infectious diseases as a clinical specialty in Germany and Europe

scientific article

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

scientific article published on 24 June 2016

Intra- and inter-individual variability of Aspergillus fumigatus reactive T-cell frequencies in healthy volunteers in dependency of mould exposure in residential and working environment.

scientific article published on 08 August 2017

Is there a role for polyenes in treating invasive mycoses?

scientific article published on December 2006

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

scientific article published on 9 December 2015

Itraconazole versus fluconazole for antifungal prophylaxis.

scientific article published in April 2004

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

scientific article published on 6 December 2017

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation

scientific article published on 01 May 2014

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

scientific article

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

scientific article published on 6 May 2006

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

scientific article published in The Lancet

Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins

scientific article

Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death

scientific article published in May 2008

Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia

scientific article published on January 2004

Opportunistic infections after treatment with monoclonal antibodies

scientific article published on May 2004

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients ⬇️

scientific article published on May 5, 2011

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

scientific article published on 3 October 2017

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

scientific article published on 9 August 2017

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease

scientific article published in December 2007

Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.

scientific article

Posaconazole concentrations in the central nervous system

scientific article published on 28 September 2008

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

scientific article

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

scientific article

Position paper on current aspects of sponsoring in accredited CME.

scientific article published on 28 April 2017

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

scientific article

Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

scientific article

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

scientific article published on 09 December 2008

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation

scientific article published on 29 August 2006

Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

scientific article

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation

scientific article published in May 2009

Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality

scientific article

Risk factors for breakthrough invasive fungal infection during secondary prophylaxis

scientific article published on 12 February 2008

Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study

scientific article

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

scientific article published on 8 May 2006

Screening and contact precautions - A survey on infection control measures for multidrug-resistant bacteria in German university hospitals

scientific article

Susceptibility of A. fumigatus specific T-cell assays to pre-analytic blood storage and PBMC cryopreservation greatly depends on readout platform and analytes.

scientific article

Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study

scientific article published in October 2005

The "Choosing Wisely" initiative in infectious diseases

scientific article published on 13 March 2017

Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

scientific article published on 9 September 2003

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

scientific article published on 14 October 2008

Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

scientific article published on 12 September 2013

Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole

scientific article published on 21 February 2008

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

scientific article published on 13 August 2018

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

scientific article

[Current development in the diagnostics and therapy of systemic fungal infections in cancer patients].

scientific article

[Vaccination of the immunocompromised host].

scientific article

Paulina is supported by:

About Paulina

Help